Spain, June 18 -- Spain based GlaxoSmithKline SA has secured contract from Direccion General de Planificacion Economica for Vaccines Estimated acquisition of 46 000 doses of the vaccine against Meningococcus Serogroup B for the Vaccination Program of the Autonomous Community of Extremadura in execution of the Framework Agreement of the Ministry of Health - File 202507ACM001 Lot 16 . The value of the contract is worth 266800000 EUR .

Published by HT Digital Content Services with permission from Pivotal Sources....